ClinicalTrials.govpublic full text
Safety Study of RPE65 Gene Therapy to Treat Leber Congenital Amaurosis
retinal degeneration, retinal dystrophy, leber congenital amaurosis, rpe65, gene therapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 849647
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.